ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 232 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q3 2022. The put-call ratio across all filers is 0.85 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,624,607 | -22.7% | 101,672 | 0.0% | 0.00% | -25.0% |
| Q2 2023 | $4,690,129 | +2.7% | 101,672 | -10.7% | 0.00% | 0.0% |
| Q1 2023 | $4,564,864 | -21.4% | 113,837 | -9.2% | 0.00% | -20.0% |
| Q4 2022 | $5,806,400 | +3.6% | 125,327 | -7.4% | 0.01% | 0.0% |
| Q3 2022 | $5,605,000 | -21.4% | 135,343 | +13.3% | 0.01% | -28.6% |
| Q2 2022 | $7,127,000 | -24.9% | 119,466 | -8.6% | 0.01% | 0.0% |
| Q1 2022 | $9,496,000 | -13.6% | 130,756 | 0.0% | 0.01% | 0.0% |
| Q4 2021 | $10,995,000 | -6.8% | 130,756 | 0.0% | 0.01% | -22.2% |
| Q3 2021 | $11,793,000 | -4.4% | 130,756 | +1.1% | 0.01% | 0.0% |
| Q2 2021 | $12,334,000 | -30.7% | 129,356 | -17.2% | 0.01% | -35.7% |
| Q1 2021 | $17,793,000 | -15.3% | 156,270 | +2.9% | 0.01% | -12.5% |
| Q4 2020 | $21,013,000 | +113.2% | 151,797 | +26.6% | 0.02% | +77.8% |
| Q3 2020 | $9,858,000 | +9.8% | 119,941 | +4.5% | 0.01% | 0.0% |
| Q2 2020 | $8,980,000 | +66.2% | 114,800 | -5.6% | 0.01% | +28.6% |
| Q1 2020 | $5,403,000 | -1.2% | 121,613 | -5.0% | 0.01% | +40.0% |
| Q4 2019 | $5,469,000 | +12.3% | 128,041 | +12.5% | 0.01% | 0.0% |
| Q3 2019 | $4,869,000 | +20.4% | 113,815 | +78.7% | 0.01% | 0.0% |
| Q2 2019 | $4,044,000 | -11.7% | 63,691 | -3.6% | 0.01% | -16.7% |
| Q1 2019 | $4,581,000 | +66.9% | 66,053 | +4.7% | 0.01% | +50.0% |
| Q4 2018 | $2,744,000 | -47.5% | 63,105 | -7.9% | 0.00% | -42.9% |
| Q3 2018 | $5,230,000 | -6.0% | 68,505 | -5.3% | 0.01% | -12.5% |
| Q2 2018 | $5,561,000 | +41.1% | 72,337 | -6.4% | 0.01% | +33.3% |
| Q1 2018 | $3,942,000 | +4.9% | 77,300 | -4.6% | 0.01% | +20.0% |
| Q4 2017 | $3,757,000 | +75.1% | 81,000 | +101.0% | 0.01% | +66.7% |
| Q3 2017 | $2,146,000 | -11.7% | 40,300 | +3.1% | 0.00% | -25.0% |
| Q2 2017 | $2,429,000 | -6.4% | 39,100 | +2.1% | 0.00% | 0.0% |
| Q1 2017 | $2,596,000 | -7.7% | 38,300 | -4.2% | 0.00% | -20.0% |
| Q4 2016 | $2,812,000 | -0.9% | 40,000 | 0.0% | 0.01% | 0.0% |
| Q3 2016 | $2,838,000 | +35.3% | 40,000 | -6.8% | 0.01% | +66.7% |
| Q2 2016 | $2,098,000 | -33.7% | 42,900 | -14.2% | 0.00% | -40.0% |
| Q1 2016 | $3,166,000 | -49.0% | 50,000 | -9.6% | 0.01% | -50.0% |
| Q4 2015 | $6,204,000 | +25.3% | 55,300 | +7.6% | 0.01% | +25.0% |
| Q3 2015 | $4,950,000 | -5.9% | 51,400 | 0.0% | 0.01% | 0.0% |
| Q2 2015 | $5,263,000 | +65.3% | 51,400 | -7.1% | 0.01% | +100.0% |
| Q1 2015 | $3,183,000 | 0.0% | 55,355 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $3,183,000 | +356.0% | 55,355 | +348.9% | 0.00% | +300.0% |
| Q3 2014 | $698,000 | +211.6% | 12,330 | +146.6% | 0.00% | – |
| Q2 2014 | $224,000 | -15.2% | 5,000 | 0.0% | 0.00% | – |
| Q1 2014 | $264,000 | – | 5,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 519,119 | $40,605,000 | 3.00% |
| First Light Asset Management, LLC | 236,958 | $18,535,000 | 2.16% |
| SECTOR GAMMA AS | 108,734 | $8,505,000 | 1.76% |
| Rock Springs Capital Management LP | 646,841 | $50,596,000 | 1.39% |
| Atika Capital Management LLC | 79,000 | $6,180,000 | 0.80% |
| Capital Impact Advisors, LLC | 30,582 | $2,392,000 | 0.80% |
| FEDERATED HERMES, INC. | 4,080,359 | $319,166,000 | 0.79% |
| Rhenman & Partners Asset Management AB | 61,500 | $4,811,000 | 0.52% |
| Ikarian Capital, LLC | 73,500 | $5,749,000 | 0.46% |
| Capital International, Inc./CA/ | 477,858 | $37,378,000 | 0.46% |